| Zachary Glicksman, MD | |
|
330 Mt. Auburn St, Cambridge, MA 02138 | |
| (339) 204-9516 | |
| Not Available |
| Full Name | Zachary Glicksman |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 12 Years |
| Location | 330 Mt. Auburn St, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790041176 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 270239 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Auburn Hospital | Cambridge, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associated Physicians Of Harvard Medical Faculty Physicians At Beth Is | 6305749987 | 440 |
News Archive
You think that your immune system is there to protect you. But what happens when it starts working against you? In the earliest stages of cancer formation, the immune system is forced to make a momentous decision. It either activates and suppresses tumor growth to help the body fight disease, or it becomes dysfunctional, helping the tumor grow and making treatment more difficult. Because this tipping point occurs before a person even realizes something is wrong, doctors are unable to directly observe this critical stage.
MIT professor Ram Sasisekharan's three biotech companies — Momenta Pharmaceuticals, Cerulean Pharma, and Visterra — share a similar goal.
ALOKA CO., LTD. announced that the ProSound Alpha 6, the company's recently introduced compact, yet versatile and ergonomic diagnostic ultrasound system, was presented the iF Product Design Award 2010.
Oncotarget published "The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma" which reported that the impact of neoadjuvant concurrent chemoradiation on exosomal markers expression and their prognostic significance in patients with rectal adenocarcinoma are yet to be explored.
› Verified 2 days ago
| Entity Name | Anaesthesia Associates Of Massachusetts, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568415289 PECOS PAC ID: 5193611267 Enrollment ID: O20040225000842 |
News Archive
You think that your immune system is there to protect you. But what happens when it starts working against you? In the earliest stages of cancer formation, the immune system is forced to make a momentous decision. It either activates and suppresses tumor growth to help the body fight disease, or it becomes dysfunctional, helping the tumor grow and making treatment more difficult. Because this tipping point occurs before a person even realizes something is wrong, doctors are unable to directly observe this critical stage.
MIT professor Ram Sasisekharan's three biotech companies — Momenta Pharmaceuticals, Cerulean Pharma, and Visterra — share a similar goal.
ALOKA CO., LTD. announced that the ProSound Alpha 6, the company's recently introduced compact, yet versatile and ergonomic diagnostic ultrasound system, was presented the iF Product Design Award 2010.
Oncotarget published "The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma" which reported that the impact of neoadjuvant concurrent chemoradiation on exosomal markers expression and their prognostic significance in patients with rectal adenocarcinoma are yet to be explored.
› Verified 2 days ago
| Entity Name | Associated Physicians Of Harvard Medical Faculty Physicians At Beth Is |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1245773308 PECOS PAC ID: 6305749987 Enrollment ID: O20170628003015 |
News Archive
You think that your immune system is there to protect you. But what happens when it starts working against you? In the earliest stages of cancer formation, the immune system is forced to make a momentous decision. It either activates and suppresses tumor growth to help the body fight disease, or it becomes dysfunctional, helping the tumor grow and making treatment more difficult. Because this tipping point occurs before a person even realizes something is wrong, doctors are unable to directly observe this critical stage.
MIT professor Ram Sasisekharan's three biotech companies — Momenta Pharmaceuticals, Cerulean Pharma, and Visterra — share a similar goal.
ALOKA CO., LTD. announced that the ProSound Alpha 6, the company's recently introduced compact, yet versatile and ergonomic diagnostic ultrasound system, was presented the iF Product Design Award 2010.
Oncotarget published "The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma" which reported that the impact of neoadjuvant concurrent chemoradiation on exosomal markers expression and their prognostic significance in patients with rectal adenocarcinoma are yet to be explored.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zachary Glicksman, MD 144 Gould St Ste 150, Needham Heights, MA 02494-2309 Ph: (339) 204-9516 | Zachary Glicksman, MD 330 Mt. Auburn St, Cambridge, MA 02138 Ph: (339) 204-9516 |
News Archive
You think that your immune system is there to protect you. But what happens when it starts working against you? In the earliest stages of cancer formation, the immune system is forced to make a momentous decision. It either activates and suppresses tumor growth to help the body fight disease, or it becomes dysfunctional, helping the tumor grow and making treatment more difficult. Because this tipping point occurs before a person even realizes something is wrong, doctors are unable to directly observe this critical stage.
MIT professor Ram Sasisekharan's three biotech companies — Momenta Pharmaceuticals, Cerulean Pharma, and Visterra — share a similar goal.
ALOKA CO., LTD. announced that the ProSound Alpha 6, the company's recently introduced compact, yet versatile and ergonomic diagnostic ultrasound system, was presented the iF Product Design Award 2010.
Oncotarget published "The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma" which reported that the impact of neoadjuvant concurrent chemoradiation on exosomal markers expression and their prognostic significance in patients with rectal adenocarcinoma are yet to be explored.
› Verified 2 days ago
Mr. David Frank Pincus, M.D., PH.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1493 Cambridge St, Cambridge Hospital, Cambridge, MA 02139 Phone: 617-665-1630 Fax: 617-665-1091 | |
Dr. James Martin Quinn, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1439 Cambridge St, Cambridge Hospital Anesthesia, Cambridge, MA 02139 Phone: 617-665-1630 Fax: 617-665-1091 | |
Sharon Herman-berreby, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 330 Mount Auburn St, Cambridge, MA 02138 Phone: 617-492-3500 | |
Dr. Stephen Lewis Campo, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Anesthesiology, Cambridge, MA 02139 Phone: 617-665-1630 | |
Mark Germani, Anesthesiology Medicare: Medicare Enrolled Practice Location: 330 Mount Auburn St, Cambridge, MA 02138 Phone: 617-492-3500 | |
Jonathan Erdman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 330 Mount Auburn St, Cambridge, MA 02138 Phone: 617-492-3500 | |
James B Streisand, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 Phone: 617-768-6045 |